Editorial: evidence is growing for protective effects of 5-aminosalicylates against colitis-associated cancer-authors' reply

Aliment Pharmacol Ther. 2017 Jun;45(12):1554-1555. doi: 10.1111/apt.14084.

S Bonovas¹, G Fiorino¹, T Lytras^{2

3

4}, G Nikolopoulos⁵, L Peyrin-Biroulet⁶, S Danese^{1

7}

¹ Department of Gastroenterology, IBD Center, Humanitas Clinical and Research Center, Milan, Italy.
² Hellenic Center for Disease Control and Prevention, Athens, Greece.
³ Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain.
⁴ Barcelona Institute for Global Health, Barcelona, Spain.
⁵ Medical School, University of Cyprus, Nicosia, Cyprus.
⁶ Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.
⁷ Department of Biomedical Sciences, Humanitas University, Milan, Italy.

No abstract available

Publication types